Conversely, in patients with both PrP and other AP co-pathology, if PrP aggregation predominates over those of other APs, CJD may be phenotypically predominant over other neurodegenerative diseases, such as AD and PD (Figure 2(c)). The gene discussed is PRNP; the disease is Parkinson disease.